Use of clinical risk assessments in evaluation of nucleic acid amplification tests for HIV/tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 2 SUPPL. 1, 2000, Pages

  Perry, S ^a   Catanzaro, A ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ACID FAST BACTERIUM; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SPUTUM SMEAR; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIOLOGICAL TECHNIQUES; EVALUATION STUDIES; FEMALE; HIV SEROPOSITIVITY; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 0034006018     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Centers for Disease Control and Prevention. Nucleic acid amplification tests for tuberculosis. MMWR 1996; 45: 950-952.
2. Rapid diagnostic tests for tuberculosis: what is the appropriate use? American Thoracic Society Workshop [see comments]. Am J Respir Crit Care Med 1997; 155: 1804-1814.
3. Doern G V. Diagnostic mycobacteriology: where are we today? J Clin Microbiol 1996; 34: 1873-1876.
4. Roos B R, van Cleeff M R, Githui W A, et al. Cost-effectiveness of the polymerase chain reaction versus smear examination for the diagnosis of tuberculosis in Kenya: a theoretical model. Int J Tuberc Lung Dis 1998; 2: 235-241.
5. Hoffner S E, Norberg R, Carlos Toro J, et al. Direct detection of Mycobacterium tuberculosis in sputum samples from Guinea Bissau by an rRNA target-amplified test system. Tubercle Lung Dis 1996; 77: 67-70.
6. Schluger N W, Kinney D, Harkin T J, Rom W N. Clinical utility of the polymerase chain reaction in the diagnosis of infections due to Mycobacterium tuberculosis. Chest 1994; 105: 1116-1121.
7. Chin D P, Yajko D M, Hadley W K, et al. Clinical utility of a commercial test based on the polymerase chain reaction for detecting Mycobacterium tuberculosis in respiratory specimens. Am J Respir Crit Care Med 1995; 151: 1872-1877.
8. Bradley S P, Reed S L, Catanzaro A. Clinical efficacy of the amplified Mycobacterhim tuberculosis direct test for the diagnosis of pulmonary tuberculosis. Am J Respir Crit Care Med 1996; 153: 1606-1610.
9. Cohen R A, Muzaffar S, Schwanz D, et al. Diagnosis of pulmonary tuberculosis using PCR assays on sputum collected within 24 hours of hospital admission. Am J Respir Crit Care Med 1998; 157: 156-161.
10. Barnes P F. Rapid diagnostic tests for tuberculosis: progress but no gold standard [editorial; comment]. Am J Respir Crit Care Med 1997; 155: 1497-1498.
11. Perry S, Catanzaro A. Clinical utility of rapid diagnostic test for TB based on clinical suspicion of disease. Am J Respir Crit Care Med 1999; 159: A495.
12. Hopewell P C. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis 1992; 15: 540-547.
13. Havlir D V, Barnes P F. Tuberculosis in patients with human immunodeficiency virus infection. N Kngl J Med 1999; 340: 367-373.
14. Raviglione M C, Narain J P, Kochi A. HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment. Bull World Health Organ 1992; 70: 515-526.
15. Chaisson R E, Schecter G F, Theuer C P, Rutherford G W, Echenberg D F, Hopewell P C. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis 1987; 136: 570-574.
16. Batungwanayo J, Taelman H, Dhote R, Bogaerts J, Allen S, Van de Perre P. Pulmonary tuberculosis in Kigali, Rwanda. Impact of human immunodeficiency virus infection on clinical and radiographic presentation. Am Rev Respir Dis 1992; 146: 53-56.
17. Foulds J, O'Brien R. New tools for the diagnosis of tuberculosis: the perspective of developing countries [see comments). Int J Tuberc Lung Dis 1998; 2: 778-783.
18. Chan I S, Neaton J D, Saravolatz L D, Crane L R, Osterberger J. Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS. AIDS 1995; 9: 1145-1151.
19. El-Solh A A, Nopper J, Abdul-Khoudoud M R, Sherif S M, Aquilina A T, Grant B J. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients. Chest 1998; 114: 138-145.
20. Pablos-Mendez A, Sterling T R, Frieden T R. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis [see comments]. JAMA 1996; 276: 1223-1228.
21. Cantwell M F, Snider D E, Jr., Cauthen G M, Onorato I M. Epidemiology of tuberculosis in the United States, 1985 through 1992 [see comments]. JAMA 1994; 272: 535-539.
22. Ransohoff D F, Feinstein A R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978; 299: 926-930.
23. Begg C B, Greenes R A. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 1983; 39: 207-215.
24. Diamond G A, Forrester J S. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979; 300: 1350-1358.
25. Schulman K A, Escarce J J, Eisenherg J M, et al. Assessing physicians' estimates of the probability of coronary artery disease: the influence of patient characteristics [see comments]. Med Dec Making 1992; 12: 109-114.
26. Bock N N, McGowan J E Jr, Ahn J, Tapia J, Blumberg H M. Clinical predictors of tuberculosis as a guide for a respiratory isolation policy. Am J Respir Crit Care Med 1996; 154: 1468-1472.
27. Mylotte J M, Rodgers J, Fassl M, Seibel K, Vacanti A. Derivation and validation of a pulmonary tuberculosis prediction model [see comments]. Infect Control Hosp Epidemiol 1997; 18: 554-560.
28. El-Solh A, Mylotte J, Sherif S, Serghani J, Grant B J. Validity of a decision tree for predicting active pulmonary tuberculosis. Am J Respir Crit Care Med 1997; 155: 1711-1716.
29. Tattevin P, Casalino E, Fleury L, Egmann G, Ruel M, Bouvet E. The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis. Chest 1999; 115: 1248-1253.